Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
PRESENTED BYNOOR HASVENDA  LILY SOPHIA AHMAD SAUFE
OUR STAND
R&D? Creative work undertaken on a systematic basis in order to  increase the stock of knowledge, including knowledge of ...
BIOTECHNOLOGY? Malaysia aspires to be a biotechnology hub and this is  clearly spelled out in the National Biotechnology ...
FOREIGN TECHNOLOGY TRANSFER? The process of sharing of skills, knowledge, technologies, methods of manufacturing, samples...
PHASES OF                                     BIOTECHNOLOGYPHASE 3 (2015 – 2020)       PHASE 2 (2010 – 2015)              ...
Initiatives under the National Biotechnology Policy are implemented within timeframe         of the thin timeframe of the ...
KEY AREAS R&D key indicator Funding Expertise/resources/agencies Intelectual property R&D Resources & Infrastucture
Funding Seed Fund  Seed or start-up fund with maximum amount of up to  RM2.5 million for bio-entrepreneurs at the beginni...
 Malaysian Technology Development Corporation  (MTDC) MTDC offers 3 type of funds for  Biotechnology Industry which inclu...
Expertise/resources/agencies Malaysia Technology Development Corporation BIOTECH CORP Malaysia Biotechnology Informatio...
Intelectual property SIRIM BHD    Full ranger of IP services: patent information services,     opinion writing and paten...
Collaborations Massachusetts Institute of Technology (MIT), USA National Cancer Institute, USA Medichem Research of Lem...
Advantage of R&D in Biotechnology                       Biotechnology Industrial                            Development   ...
ADVANTAGE OF R&D IN BIOTECHNOLOGY Biotechnology Industrial Development  -Transform and enhance the value creation of the ...
 Engaging professional participation  Broadening the scope of R&D exploration by engaging  commitment of a dedicated and ...
CONCLUSION Malaysia has identified biotechnology to be the new engine  of growth for the country and with its rich biodiv...
Q & A SESSION
R & d @ tech transfer
R & d @ tech transfer
R & d @ tech transfer
R & d @ tech transfer
Upcoming SlideShare
Loading in …5
×

R & d @ tech transfer

992 views

Published on

  • Be the first to comment

  • Be the first to like this

R & d @ tech transfer

  1. 1. PRESENTED BYNOOR HASVENDA LILY SOPHIA AHMAD SAUFE
  2. 2. OUR STAND
  3. 3. R&D? Creative work undertaken on a systematic basis in order to increase the stock of knowledge, including knowledge of man, culture and society, and the use of this stock of knowledge to devise new applications" Techniques that involve science, technology and mathematics. R&D has a special economic significance apart from its conventional association with scientific and technological development. R&D investment generally reflects a governments or organizations willingness to forgo current operations or profit to improve future performance or returns, and its abilities to conduct research and development.
  4. 4. BIOTECHNOLOGY? Malaysia aspires to be a biotechnology hub and this is clearly spelled out in the National Biotechnology Policy that was launched on the 28th April 2005. The policy envisions that biotechnology will be a new economic engine for Malaysia, enhancing the nation’s prosperity and well-being. Among the type of biotechnology in Malaysia are Agricultural Biotechnology, Food Biotechnology and Medical Biotechnology.
  5. 5. FOREIGN TECHNOLOGY TRANSFER? The process of sharing of skills, knowledge, technologies, methods of manufacturing, samples of manufacturing and facilities among governments and other institutions to ensure that scientific and technological developments are accessible to a wider range of users who can then further develop and exploit the technology into new products, processes, applications, materials or services. (Hargadon, Andrew, 2003)
  6. 6. PHASES OF BIOTECHNOLOGYPHASE 3 (2015 – 2020) PHASE 2 (2010 – 2015) PHASE 1 (2005-2010)
  7. 7. Initiatives under the National Biotechnology Policy are implemented within timeframe of the thin timeframe of the Biotechnology Master Plan from 2005-2020
  8. 8. KEY AREAS R&D key indicator Funding Expertise/resources/agencies Intelectual property R&D Resources & Infrastucture
  9. 9. Funding Seed Fund Seed or start-up fund with maximum amount of up to RM2.5 million for bio-entrepreneurs at the beginning stage of setting up business or companies R&D Matching Fund Matching fund with maximum amount of RM1 million to assist biotechnology companies execute research & development (R&D) projects
  10. 10.  Malaysian Technology Development Corporation (MTDC) MTDC offers 3 type of funds for Biotechnology Industry which includes Non-ICT Venture Fund, Technology Acquisition Fund (TAF) & Commercialization of R&D Fund (CRDF) SME Bank ‘Program Usahawan Bioteknologi’ is one of the initiative provided by SME Bank for small & medium enterprises to accelerate their business growth in Biotechnology Industry
  11. 11. Expertise/resources/agencies Malaysia Technology Development Corporation BIOTECH CORP Malaysia Biotechnology Information Centre (MBIC) Malaysian Industrial Development Authority (MIDA) Forest Research Institute of Malaysia (FRIM) MARDI MPOB MRB Higher Learning Institution: Apex University
  12. 12. Intelectual property SIRIM BHD  Full ranger of IP services: patent information services, opinion writing and patent drafting.  Rapid prototyping services  Product testing and certification  Technology incubator services
  13. 13. Collaborations Massachusetts Institute of Technology (MIT), USA National Cancer Institute, USA Medichem Research of Lemont, Illinois, USA Nimura Genetic Solutions, Japan Functional Food Creation Research Institute Co. Ltd., Japan Cambridge University, UK Centre for Genetic Engineering and Biotechnology, Cuba (CIBG)
  14. 14. Advantage of R&D in Biotechnology Biotechnology Industrial Development Lead to Human Capital Development Financial Infrastructure Development that will lead to future Strategic positioning economic growth that contribute to competitive advantages Engaging professional participation
  15. 15. ADVANTAGE OF R&D IN BIOTECHNOLOGY Biotechnology Industrial Development -Transform and enhance the value creation of the sector. -Able to bring together multidisciplinary research teams to accommodate co-ordinate research and commercialization initiatives. -It also accelerates technology development via strategic acquisitions. Lead to Human Capital Development -Potentially building our nation’s biotech human resource capability and talent that is in line with market needs through special schemes, programmes and training. Strategic positioning that contribute to competitive advantages -Ability to establish a global marketing strategy in the effort to build recognition for Malaysian biotech and benchmark progress. -Establish our country as a centre for Contract Research Organizations and Contract Manufacturing Organizations
  16. 16.  Engaging professional participation Broadening the scope of R&D exploration by engaging commitment of a dedicated and professional agencies that overseeing the development of Malaysia’s biotech industry. This will increase the opportunities for a high quality result. Financial Infrastructure Development that will lead to future economic growth New investment area in R&D by stimulating funding and incentives to promote committed participation by the private sector as well as government-linked companies.
  17. 17. CONCLUSION Malaysia has identified biotechnology to be the new engine of growth for the country and with its rich biodiversity and cost-competitive skilled labor markets combined with good transportation and ICT infrastructure as well as strong support in R&D. Biotechnology as a key driver of growth for Malaysia and is expected to generate RM270 billion in revenue for the country by 2020. With adequate funding,expertise,R&D Resources & Infrastucture,we believe that investment in R&D is better option than having a foreign technology transfer.
  18. 18. Q & A SESSION

×